BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20013612)

  • 21. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-incidental papillary microcarcinomas of the thyroid].
    Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
    Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous occurrence of papillary intrafollicular and microcarcinomas with bilateral medullary microcarcinoma of the thyroid in a patient with multiple endocrine neoplasia type 2A: report of a case.
    Kösem M; Kotan C; Algün E; Topal C
    Surg Today; 2002; 32(7):623-8. PubMed ID: 12111520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatment of incidental and non-incidental papillary thyroid microcarcinoma.
    Xu YN; Wang JD
    G Chir; 2010 May; 31(5):205-9. PubMed ID: 20615360
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proliferative activity of thyroid papillary microcarcinoma].
    Lantsov DS
    Arkh Patol; 2006; 68(5):16-9. PubMed ID: 17144524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioactive iodine in the treatment of thyroid carcinoma].
    Pendić S; Tasić S
    Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression and significance of c-met protein in papillary thyroid carcinoma.
    Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
    Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 131-I-therapy of malignant thyroid disease in regard to its classification.
    Hoffmann G
    Acta Endocrinol Suppl (Copenh); 1973 Oct; 179():93-4. PubMed ID: 4523788
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Papillary microcarcinoma of the thyroid].
    Santini L; Conzo G; Caracò C; Aniello Papale P
    G Chir; 1996 Oct; 17(10):488-92. PubMed ID: 9044600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship of methylation of promoter and expression of PTEN gene in papillary thyroid carcinoma].
    Yin DT; Yin FY; Zheng LY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 45(4):330-3. PubMed ID: 20627056
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thyroid microcarcinoma].
    Lantsov DS
    Arkh Patol; 2006; 68(4):54-7. PubMed ID: 16986502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein e expression in anaplastic thyroid carcinoma.
    Ito Y; Takano T; Miyauchi A
    Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between thyroid-stimulating hormone-peroxiredoxin1 signaling pathway and invasion of papillary thyroid carcinoma].
    Liu X; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 44(4):287-91. PubMed ID: 19558833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fulminant lethal spread of occult papillary microcarcinoma of the thyroid.
    Marcy PY; Thariat J; Peyrottes I; Benezery K; Benisvy D; Dassonville O; Santini J
    Thyroid; 2010 Apr; 20(4):445-8. PubMed ID: 20373990
    [No Abstract]   [Full Text] [Related]  

  • 38. The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target.
    Nowicki TS; Moscatello AL; Shin E; Schantz S; Tiwari RK; Geliebter J
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3062-4. PubMed ID: 21832115
    [No Abstract]   [Full Text] [Related]  

  • 39. Papillary thyroid carcinoma metastasizing to the sphenoid-ethmoid sinuses and skull base.
    Freeman JL; Gershon A; Liavaag PG; Walfish PG
    Thyroid; 1996 Feb; 6(1):59-61. PubMed ID: 8777386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.
    Avram AM; Gielczyk R; Su L; Vine AK; Sisson JC
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5303-7. PubMed ID: 15531474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.